Patterns of Prescribing and Monitoring of Palbociclib

Clinical trial NCT03285568 · COMPLETED

Trial details

NCT number: NCT03285568
Sponsor: Rush University Medical Center
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Breast Cancer Advanced Breast Cancer Estrogen Receptor-positive Breast Cancer Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Start date: 2015-02-03
Primary completion: 2016-12-30
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.